Serplulimab
ATC L01FF12 · 5 markets · 5 records
GB 1 records · 1 strengths
- 100 mg/10 mLinjectionHetronifly 100mg/10ml concentrate for solution for infusion vials
SG 1 records · 1 strengths
- 100 mg/10 mLinjectionZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml
ES 1 records · 1 strengths
- 10 mg/1 mLinjectionHETRONIFLY
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | GB | SG | ES | HK | EU |
|---|---|---|---|---|---|
| 100 mg/10 mL injection | Hetronifly 100mg/10ml concentrate for solution for infusion vials | ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml | |||
| 10 mg/1 mL injection | HETRONIFLY | ||||
unknown | HETRONIFLY CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML | HETRONIFLY |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.